Moderate aortic stenosis: Culprit or bystander?

Varayini Pankayatselvan, Inbar Raber, David Playford, Simon Stewart, Geoff Strange, Jordan B. Strom

Research output: Contribution to journalArticlepeer-review

1 Citation (Scopus)


Non-rheumatic aortic stenosis (AS) is among the most common valvular diseases in the developed world. Current guidelines support aortic valve replacement (AVR) for severe symptomatic AS, which carries high morbidity and mortality when left untreated. In contrast, moderate AS has historically been thought to be a benign diagnosis for which the potential benefits of AVR are outweighed by the procedural risks. However, emerging data demonstrating the substantial mortality risk in untreated moderate AS and substantial improvements in periprocedural and perioperative mortality with AVR have challenged the traditional risk/benefit paradigm. As such, an appraisal of the contemporary data on morbidity and mortality associated with moderate AS and appropriate timing of valvular intervention in AS is warranted. In this review, we discuss the current understanding of moderate AS, including the epidemiology, current surveillance and management guidelines, clinical outcomes, and future studies.

Original languageEnglish
Article numbere001743
JournalOpen Heart
Issue number1
Publication statusPublished - 24 Jan 2022


  • echocardiography
  • epidemiology
  • transcatheter aortic valve replacement


Dive into the research topics of 'Moderate aortic stenosis: Culprit or bystander?'. Together they form a unique fingerprint.

Cite this